References D'Alessio D (2016): s GLP-1 a hormone: Whether and When
Semaglutide is a GLP-1 receptor agonist, which means it mimics the action of the glucagon-like peptide-1 hormone in the body
These findings indicate that liraglutide, semaglutide, and tirzepatide were each associated with significant improvements in liver enzyme levels over the 36-week treatment period, without evidence of differential effects between agents ( Changes in Liver Enzyme Levels (AST, ALT, and GGT) from Baseline to Week 36 Lipid Profile At week 36, significant within-group reductions were observed in total cholesterol, LDL cholesterol, and triglyceride levels across all treatment groups, whereas HDL cholesterol did not change significantly
For some adults, that also means combining medication-based treatment with broader lifestyle structure through a Medical Weight Loss Program, especially when excess weight, orthopedic pain, deconditioning, or prior failed weight-loss attempts are all part of the picture